Raphael Pharmaceutical (RAPH) Price to Book (2023 - 2026)

Raphael Pharmaceutical has disclosed Price to Book across 4 years of filings, most recently posting 14.99 for Q2 2026.

• In Q2 2026, Price to Book fell 6.69% year-over-year to 14.99; the TTM figure through Jun 2026 stood at 14.99 (down 6.69% YoY), while the FY2025 annual figure was 19.71, down 200.8% from the prior year.
• Price to Book came in at 14.99 for Q2 2026 at Raphael Pharmaceutical, up from 19.71 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 172.92 in Q4 2023 to a low of 1813.65 in Q1 2023.
• Average Price to Book over 4 years is 208.03, with a median of 26.74 recorded in 2025.
• Year-over-year, Price to Book soared 90.01% in 2024 and slumped 200.8% in 2025.
• Over 4 years, Price to Book stood at 172.92 in 2023, then tumbled by 103.79% to 6.55 in 2024, then tumbled by 200.8% to 19.71 in 2025, then climbed by 23.98% to 14.99 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 14.99 in Q2 2026, 19.71 in Q4 2025, and 6.21 in Q3 2025.